OasisLMS

Electrophysiology is entering a new era where mapping must do more than reconstruct chambers and display voltage. This roundtable will explore how AI, advanced imaging, tissue characterization, signal clarity, and lesion assessment can reshape the future of cardiac mapping, including how mapping can better define substrate, reduce ambiguity, and help assess therapy effect in the era of PFA. The discussion will also address what next generation mapping platforms need to support clinically and technically, from smarter imaging integration to connected workflows that make procedural intelligence more actionable.